Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Meetings
Meetings
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Highlights from IASLC WCLC 2016
lungcanc
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
Best of the 16th World Conference on Lung Cancer in Peru
ESMO-IASLC European Lung Cancer Congress
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
First-Ever IASLC School of Nursing Held at Latin American Lung Cancer...
lungcanc
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
lungcanc
Targeted Therapies Meeting Focuses on Upcoming Research Advances in Lung Cancer
lungcanc
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
lungcanc
Honoring Superb Advocacy at the 13th Annual Prevent Cancer Quantitative Imaging...
lungcanc
Best of the 16th World Conference on Lung Cancer in Peru
lungcanc
The Long Road Home
lungcanc
The IASLC’s Spotlight on Screening
lungcanc
Scientific Highlights from the IASLC Latin America Conference on Lung Cancer
lungcanc
IASLC WCLC 2017 Presidential Symposium Presents Leading Lung Cancer Research
lungcanc
1
2
3
...
6
Page 1 of 6
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS